Pfizer holds Wells Fargo Hold as price tops analyst target
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
Wells Fargo analyst Derek Archila maintained a Hold rating on Pfizer (PFE) with a $28.00 price target. This comes despite a Moderate Buy consensus among analysts with a slightly higher average target. Pfizer recently reported a quarterly revenue of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context